$MTNB
Matinas BioPharma Holdings, Inc.

2019 Form 10-K Financial Statement

#000149315221006979 Filed on March 29, 2021

View on sec.gov

Income Statement

Concept 2019
Revenue $89.81K
YoY Change -25.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $7.776M
YoY Change -2.54%
% of Gross Profit
Research & Development $11.23M
YoY Change 65.52%
% of Gross Profit
Depreciation & Amortization $328.8K
YoY Change 50.59%
% of Gross Profit
Operating Expenses $19.01M
YoY Change 28.74%
Operating Profit
YoY Change
Interest Expense $541.3K
YoY Change 857.21%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$17.37M
YoY Change 19.07%
Income Tax
% Of Pretax Income
Net Earnings -$17.37M
YoY Change 23.36%
Net Earnings / Revenue -19343.78%
Basic Earnings Per Share
Diluted Earnings Per Share -$119.7K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $27.78M
YoY Change 123.15%
Cash & Equivalents $22.17M
Short-Term Investments $5.605M
Other Short-Term Assets $2.148M
YoY Change 236.3%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $29.92M
YoY Change 128.67%
LONG-TERM ASSETS
Property, Plant & Equipment $5.627M
YoY Change 175.46%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $336.0K
YoY Change -27.11%
Total Long-Term Assets $10.32M
YoY Change 50.45%
TOTAL ASSETS
Total Short-Term Assets $29.92M
Total Long-Term Assets $10.32M
Total Assets $40.24M
YoY Change 101.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $679.3K
YoY Change 129.77%
Accrued Expenses $2.263M
YoY Change 108.24%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change -100.0%
Long-Term Debt Due $54.67K
YoY Change -34.33%
Total Short-Term Liabilities $3.097M
YoY Change 9.06%
LONG-TERM LIABILITIES
Long-Term Debt $54.51K
YoY Change -49.37%
Other Long-Term Liabilities $3.696M
YoY Change 620.8%
Total Long-Term Liabilities $3.750M
YoY Change 504.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.097M
Total Long-Term Liabilities $3.750M
Total Liabilities $7.189M
YoY Change 89.1%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $33.05M
YoY Change
Total Liabilities & Shareholders Equity $40.24M
YoY Change 101.77%

Cashflow Statement

Concept 2019
OPERATING ACTIVITIES
Net Income -$17.37M
YoY Change 23.36%
Depreciation, Depletion And Amortization $328.8K
YoY Change 50.59%
Cash From Operating Activities -$14.09M
YoY Change 36.54%
INVESTING ACTIVITIES
Capital Expenditures -$405.6K
YoY Change -24.32%
Acquisitions
YoY Change
Other Investing Activities -$5.606M
YoY Change
Cash From Investing Activities -$6.011M
YoY Change 1021.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 29.85M
YoY Change 88.14%
NET CHANGE
Cash From Operating Activities -14.09M
Cash From Investing Activities -6.011M
Cash From Financing Activities 29.85M
Net Change In Cash 9.749M
YoY Change 94.59%
FREE CASH FLOW
Cash From Operating Activities -$14.09M
Capital Expenditures -$405.6K
Free Cash Flow -$13.69M
YoY Change 39.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
USD
CY2019 MTNB Issuance Of Common Stock In Exchange For Preferred Shares
IssuanceOfCommonStockInExchangeForPreferredShares
USD
CY2019 MTNB Issuance Of Common Stock In Exchange For Preferred Shares B
IssuanceOfCommonStockInExchangeForPreferredSharesB
USD
CY2020 MTNB Issuance Of Common Stock In Exchange For Preferred Shares B
IssuanceOfCommonStockInExchangeForPreferredSharesB
USD
CY2020 us-gaap Dividends Stock
DividendsStock
USD
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
USD
CY2019 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
USD
CY2019 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
USD
CY2019 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
USD
CY2020 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
USD
CY2020 MTNB Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
USD
CY2019 MTNB Noncash Prepaid From Exercise Of Options
NoncashPrepaidFromExerciseOfOptions
USD
CY2020 MTNB Stock Dividends Accrual
StockDividendsAccrual
USD
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
USD
CY2020 MTNB Preferred Stock Conversion Into Common Stock Series
PreferredStockConversionIntoCommonStockSeries
USD
CY2020 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 Segments
CY2020 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
USD
CY2019 MTNB Cash And Cash Equivalents Unrealized Loss
CashAndCashEquivalentsUnrealizedLoss
USD
CY2019 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
USD
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
USD
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
USD
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
USD
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
USD
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
USD
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
USD
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
USD
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
USD
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
USD
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
USD
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
CY2019 MTNB Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Tendered
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsTendered
shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
CY2020 MTNB Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Tendered
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsTendered
shares
CY2018Q4 MTNB Available For Sales Securities Debt Securities
AvailableForSalesSecuritiesDebtSecurities
USD
CY2018Q4 MTNB Accumulated Other Comprehensive Income Loss Net
AccumulatedOtherComprehensiveIncomeLossNet
USD
CY2019 MTNB Availableforsale Securities Reclassifications To Net Loss
AvailableforsaleSecuritiesReclassificationsToNetLoss
USD
CY2019 MTNB Accumulated Other Comprehensive Lossgain Reclassifications To Net Income
AccumulatedOtherComprehensiveLossgainReclassificationsToNetIncome
USD
CY2020Q4 MTNB Accured Deferred Revenue And Other Deferred Liabilities
AccuredDeferredRevenueAndOtherDeferredLiabilities
643000 USD
CY2019Q4 MTNB Accured Deferred Revenue And Other Deferred Liabilities
AccuredDeferredRevenueAndOtherDeferredLiabilities
100000 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
5397000 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
5397000 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
2576000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
1328000 shares

Files In Submission

Name View Source Status
0001493152-21-006979-index-headers.html Edgar Link pending
0001493152-21-006979-index.html Edgar Link pending
0001493152-21-006979.txt Edgar Link pending
0001493152-21-006979-xbrl.zip Edgar Link pending
ex10-10.htm Edgar Link pending
ex10-10_001.jpg Edgar Link pending
ex21-1.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex4-6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_001.jpg Edgar Link pending
form10-k_002.jpg Edgar Link pending
form10-k_003.jpg Edgar Link pending
form10-k_004.jpg Edgar Link pending
form10-k_005.jpg Edgar Link pending
form10-k_006.jpg Edgar Link pending
form10-k_007.jpg Edgar Link pending
form10-k_008.jpg Edgar Link pending
form10-k_009.jpg Edgar Link pending
form10-k_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
mtnb-20201231.xsd Edgar Link pending
mtnb-20201231_cal.xml Edgar Link unprocessable
mtnb-20201231_def.xml Edgar Link unprocessable
mtnb-20201231_lab.xml Edgar Link unprocessable
mtnb-20201231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending